Definitive Contract HHSN261201000135C
Award Date 9/30/10
Potential Completion Date 11/29/11
Potential Value $183K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
19
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $199,987.00 firm fixed price definitive contract awarded by the National Cancer Institute, a civilian agency, to Genome Data Systems Inc., a minority-owned, small disadvantaged business, for "OTHER FUNCTIONS GENOME "PHASE I, TOPIC 309, LABEL FREE MULTIVARIATE CANCER DIAGNOSIS"". The contract has a total small business set-aside designation and was awarded on September 28, 2012, with a completion date of June 27, 2013. Genome Data Systems Inc. has previously received...
- <p>This is a definitive contract awarded by the National Cancer Institute, a civilian agency, to The International Genomics Consortium. The contract, with a ceiling value of $21,332,413.15, supports the Cancer Genome Atlas (TCGA) program through the establishment of Tissue Source Site (TSS) networks. The contract does not have a set-aside designation and was awarded on September 27, 2010, with a period of performance through September 30, 2014. The contract is a cost-no-fee contract type.</p>
- <p>This is a $198,751 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Genomic Systems, LLC. The contract is for research and development in the TAS::75 0849::TAS area and has a period of performance ending on September 30, 2011. This SBIR Phase I contract was awarded on a Firm Fixed Price basis.</p>
- This is a $37,262,683.59 definitive cost-no-fee contract awarded by the National Cancer Institute (NCI) to The International Genomics Consortium. The contract is for providing biospecimen processing services to support the Cancer Genome Atlas (TCGA) program, which is part of the National Institutes of Health's efforts to comprehensively characterize various cancer types. The contract has an ultimate completion date of December 30, 2012 and was awarded on September 24, 2010 as part of the...
- This is a $1,698,988.00 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services (HHS), to Insight Genetics, Inc., a small business. The contract is for "OTHER FUNCTIONS - R & D BIOMEDICAL (BASIC RESEARCH)" and has a total small business set-aside designation. The contract was awarded on September 20, 2012 and has an ultimate completion date of August 16, 2015. This contract award is not associated...
- This federal contract award, valued at $21,600.00, was issued by the National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract was awarded to Technologist Inc., a woman-owned small business, to provide technology and administrative support services from October 21, 2024, to January 20, 2025. The contract was awarded under the General Services Administration's (GSA) Multiple Award Schedule (MAS) program, which allows...
- <p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Ilsbio LLC, a for-profit limited liability company. The contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. This award is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract and is funded under the American Recovery and Reinvestment Act (ARRA). The contract has a...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS), to Yale University. The contract is to support the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various types of cancer, as part of the American Recovery and Reinvestment Act (ARRA). The contract has a ceiling value of $76,875 and a period of performance ending on March 31, 2015. This contract was...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) in the amount of $201,998.50. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase, an indefinite delivery contract. The contract is for the recovery and provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the...